![Neil Graham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Neil Graham is currently an Independent Non-Executive Director at Aslan Pharmaceuticals Ltd. since 2021.
Former roles include Independent Non-Executive Director at Syntara Ltd. from 2020 to 2023, Independent Director at Allakos, Inc. from 2023 to 2025, Independent Non-Executive Director at Zura Bio Ltd. from 2023 to 2026, VP-Strategic Program Direction & Immunology at Regeneron Pharmaceuticals, Inc. from 2009 to 2020, SVP-Program & Portfolio Management at Trimeris, Inc. from 2005 to 2007, Chief Medical Officer & VP-Clinical Development at XTL Biopharmaceuticals Ltd. from 2002 to 2005, Senior Vice President-Program & Portfolio at Vertex, Inc. from 2007 to 2009, Associate Professor at Johns Hopkins Bloomberg School of Public Health from 1989 to 1997, Chief Medical Officer at Tiziana Life Sciences Ltd. (United Kingdom) from 2021 to 2022, Director-HIV Medical Affairs at Glaxo Wellcome Plc, Independent Director at ASLAN Pharmaceuticals Pte Ltd., and Chief Development Officer at Evelo Biosciences, Inc. Education includes a doctorate from the University of Adelaide.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/05/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 18/02/2021 |
| Società | Posizione | Fine |
|---|---|---|
| ZURA BIO LIMITED | Direttore/Membro del Consiglio | 21/02/2026 |
| ALLAKOS INC. | Direttore/Membro del Consiglio | 15/05/2025 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Direttore/Membro del Consiglio | 17/07/2024 |
| SYNTARA LIMITED | Direttore/Membro del Consiglio | 03/10/2023 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Direttore Tecnico/Scientifico/R&S | 18/07/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Syntara Ltd.
 Syntara Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceutical products for respiratory disorders | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex, Inc.
 Vertex, Inc. Packaged SoftwareTechnology Services Provides tax compliance software solutions | Technology Services |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Health Technology |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
